Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 490 of 1,261
  1. US 10329552

    Vaccine for livestock production systems

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  2. US 10329356

    Fungal-specific metalloproteases and uses thereof

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  3. US 10329353

    Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells

    The Board of Regents of the University of Texas System · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  4. US 10329563

    Organic compositions to treat HSF1-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  5. US 10329343

    Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  6. US 10328130

    Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

    HALOZYME, INC. · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  7. US 10329298

    Inhibitors of cellular metabolic processes

    Agios Pharmaceuticals, Inc. · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  8. US 10329339

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  9. US 10329283

    G protein-coupled receptor kinase inhibitors and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  10. US 10330600

    Plasmonic-magnetic bifunctional nanotubes for biological applications

    The Board of Regents of the University of Texas System · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  11. US 10328161

    Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  12. US 10328089

    Fumagillol derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  13. US 10328087

    Formulations for solubilizing hormones

    Compass Therapeutics LLC · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  14. US 10327853

    System and method of performing treatment along a lumen network

    Covidien LP · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  15. US 10328160

    Hollow silica nanospheres and methods of making same

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  16. CA 3084733

    MATERIELS ET PROCEDES POUR TRAITER LA DYSTROPHIE DES CONES ET DES BATONNETS AUTOSOMIQUE DOMINANTE

    CRISPR THERAPEUTICS AG [CH] · Granted Jun 20, 2019 · Expires Jun 15, 2039

    granted
  17. WO 2019115709

    INHIBITEURS MITOCHONDRIALES POUR LE TRAITEMENT DE TROUBLES PROLIFÉRATIFS

    BASILEA PHARM INT AG [CH] · Granted Jun 20, 2019 · Expires Jun 15, 2039

    granted
  18. US 10322113

    Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  19. US 10322146

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  20. US 10323027

    2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor

    Takeda Pharmaceutical Company Limited · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  21. US 10322095

    Endoxifen for local transdermal therapy to the breast

    Northwestern University · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  22. US 10322125

    TGF-beta enhancing compositions for cartilage repair and methods related thereto

    The United States of America as represented by the Department of Veteran Affairs · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  23. US 10325687

    Population pharmacokinetics tools and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  24. US 10324011

    Methods and devices for high throughput purification

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.